All lobbying filings

W STRATEGIES, LLC

Lobbying for INCYTE CORPORATION · â€‹Biopharmaceutical Company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Delaware · House · $60,000.00 income · posted Apr 18, 2026

Official filing document

Bills named in this filing 1

HR 946
ORPHAN Cures Act

Lobbying activity 2

Health Issues

Education around access to innovative therapies in dermatology.

Medicare/Medicaid

Issues related to Medicaid Drug Rebate program rule. Public Law 119-21: One Big Beautiful Bill Act, as it relates to H.R.946 - ORPHAN Cures Act. Issues related to drug pricing.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.